Search Results

Filter
  • 1-10 of  691 results for ""Polycythemia Vera""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

What are the future prospects for polycythemia vera pharmacotherapies for patients with hydroxyurea resistance?

  • Authors : Metzger M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Mascarenhas J

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/therapeutic use ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy ; Drug Resistance*

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Aug; Vol. 25 (12), pp. 1585-1590. Date of Electronic Publication: 2024 Aug 26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.

  • Authors : Theocharides A; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.; Gisslinger H

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/adverse effects ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/diagnosis ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 379-391. Date of Electronic Publication: 2023 Oct 30.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

×
Academic Journal

Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients.

  • Authors : Lee SE; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Hong J

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/pharmacology ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy; Humans

  • Source: Journal of Korean medical science [J Korean Med Sci] 2024 Jan 22; Vol. 39 (3), pp. e24. Date of Electronic Publication: 2024 Jan 22.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices.

  • Authors : Kuykendall AT; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, 33612, USA. .

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/therapeutic use ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/genetics

  • Source: Annals of hematology [Ann Hematol] 2023 May; Vol. 102 (5), pp. 985-993. Date of Electronic Publication: 2023 Mar 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

  • Authors : Liu D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin.

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/therapeutic use ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/diagnosis ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy

  • Source: Haematologica [Haematologica] 2022 Apr 01; Vol. 107 (4), pp. 991-995. Date of Electronic Publication: 2022 Apr 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

  • Authors : Dam MJB; Center for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.; Pedersen RK

Subjects: Alleles* ; Blood Cell Count*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2021 Dec; Vol. 107 (6), pp. 624-633. Date of Electronic Publication: 2021 Sep 30.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

×
Academic Journal

[The relationship between symptom burden and hematologic responses after treatment with interferon/hydroxyurea in patients with polycythemia vera].

  • Authors : Liu D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.; Xu ZF

Subjects: Hydroxyurea* ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/drug therapy; Female

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Aug 14; Vol. 42 (8), pp. 635-641.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium: Print ISSN: 0253-2727

Record details

×
Academic Journal

Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations.

  • Authors : Tan G; Functional Genomics Center Zurich, University and ETH Zurich, Zurich, Switzerland.; Meier-Abt F

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Hematopoietic Stem Cells/Hematopoietic Stem Cells/Hematopoietic Stem Cells/*drug effects ; Hydroxyurea/Hydroxyurea/Hydroxyurea/*pharmacology

  • Source: Experimental hematology [Exp Hematol] 2021 May; Vol. 97, pp. 47-56.e5. Date of Electronic Publication: 2021 Mar 04.Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics

  • Source: Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 623-627. Date of Electronic Publication: 2020 May 05.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.

Subjects: Hydroxyurea/Hydroxyurea/Hydroxyurea/*therapeutic use ; Nitriles/Nitriles/Nitriles/*therapeutic use ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy

  • Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Nov; Vol. 21 (11), pp. e915-e921. Date of Electronic Publication: 2021 Jul 04.Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  691 results for ""Polycythemia Vera""